Gary Lynch

Gary Lynch is a professor at the University of California, Irvine. He is the author of more than 550 scientific publications that are among the most cited in the field of neuroscience. He is the co-inventor of a novel family of cognition-enhancing drugs called "ampakines," is co-founder of three technology companies (Cortex Pharmaceuticals (NASDAQ: COR), Synaptics (NASDAQ: SYNA), and Thuris Corporation), has served as advisor to multiple professional entities including the Society for...See more

Gary Lynch is a professor at the University of California, Irvine. He is the author of more than 550 scientific publications that are among the most cited in the field of neuroscience. He is the co-inventor of a novel family of cognition-enhancing drugs called "ampakines," is co-founder of three technology companies (Cortex Pharmaceuticals (NASDAQ: COR), Synaptics (NASDAQ: SYNA), and Thuris Corporation), has served as advisor to multiple professional entities including the Society for Neuroscience and the Jet Propulsion Laboratory, and has been featured in major television networks, newspapers, and magazines ranging from the "Los Angeles Times" to "Popular Science," Richard Granger is W.H. Neukom Distinguished Professor of Computational Science and of Psychological and Brain Sciences at Dartmouth. He has been the principal architect of a series of advanced computational systems for military, commercial and medical applications, and co-inventor of FDA-approved devices and drugs. He is a consultant, co-founder, and board member of numerous technology corporations such as Thuris Corporation and Cortex Pharmaceuticals, and government research agencies including the Defense Advanced Research Projects Agency, the National Science Foundation, and the Office of Naval Research. His work has been highlighted in numerous popular press and television features, including recent stories in "Forbes," "Wired," and on CNN. See less